UAE Gene Therapy Market to Grow with a CAGR of 3.70% through 2030
Surge in research and development activities is
expected to drive the UAE Gene Therapy Market growth in the forecast period,
2026-2030.
According to TechSci Research report, “UAE Gene Therapy
Market - By Region, Competition, Forecast & Opportunities, 2030F”,
the UAE Gene Therapy Market stood at USD 50.36 Million in 2024 and is
anticipated to grow with a CAGR of 3.70% through 2030. Initiatives taken by
government based on gene therapy has led to favorable market conditions for the
UAE Gene Therapy Market. Several factors contribute to the growth of various gene
therapy products.
The UAE government has established a supportive
regulatory environment for the development and integration of gene therapies
within the healthcare system. The Ministry of Health and Prevention (MOHAP) has
implemented regulatory frameworks that provide clear guidelines for the
approval and use of gene therapies in clinical settings. These regulations are designed
to ensure patient safety while facilitating the introduction of innovative
therapies. The UAE has also created pathways for the fast-track approval of
cutting-edge medical treatments, including gene therapies, enabling timely
access to life-saving treatments.
The rise in R&D activities is fostering the development of advanced technologies such as gene editing tools, viral vector systems, and personalized genetic diagnostics, all of which are crucial components of gene therapy. These innovations are making it possible to target and correct genetic mutations with greater precision and efficiency, driving the evolution of gene therapies into a more practical and viable treatment option. The continuous advancement of R&D is not only enhancing the efficacy of existing gene therapies but is also leading to the discovery of new therapeutic approaches that could revolutionize the treatment landscape in the UAE.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "UAE Gene Therapy Market”
The UAE Gene Therapy Market is segmented into type,
application, regional distribution, and company.
Based on Type, Gene Silencing have
emerged as the dominating segment in the UAE Gene Therapy Market in 2024. One
of the primary factors driving the dominance of gene silencing is its potential
to target and suppress the expression of problematic genes at the molecular
level. This is particularly beneficial for treating diseases where genetic
mutations lead to the overproduction of harmful proteins, such as in conditions
like Huntington’s disease, certain types of cancer, and cardiovascular
disorders. Gene silencing techniques, which can directly modulate gene
expression, offer a precise and non-invasive alternative to traditional
methods, making them highly attractive to healthcare providers in the UAE. As
the technology continues to advance, it holds promise for treating a broader
range of diseases, further expanding its role in the UAE’s healthcare
landscape.
Based on Region, Abu Dhabi have emerged as the fastest
growing region in the UAE Gene Therapy Market in 2024. Abu Dhabi has actively
sought collaborations with global pharmaceutical and biotechnology companies
specializing in gene therapy. These partnerships not only facilitate knowledge
transfer but also bring advanced gene therapies to the region more quickly. The
influx of international expertise accelerates the adoption of cutting-edge
treatments and solidifies Abu Dhabi’s position as a regional leader in gene
therapy.
Major companies operating in UAE Gene Therapy Market
are:
- SGS S.A.
- CureLeads
- Charles River Laboratories, Inc.
- Roche Diagnostics Middle East FZCO
- Ocugen, Inc.
Download Free Sample Report
Customers can also request for 10%
free customization on this report
“Nanotechnology enables precise targeting of specific
tissues or organs by modifying the surface characteristics of nanoparticles.
This ensures that therapeutic genes are delivered directly to the cells in
need, enhancing the overall efficacy of gene therapy. For example, lipid
nanoparticles and polymeric nanoparticles are being used to improve the delivery
of gene-editing tools, such as CRISPR-Cas9, to specific areas affected by
genetic disorders. The ability to precisely target diseased cells while sparing
healthy tissues is critical in personalized gene therapy applications, which
are gaining traction in the UAE as part of broader healthcare innovations”,
said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
management consulting firm.
“UAE Gene Therapy Market By Type (Gene
Augmentation, Gene Silencing, Others), By Application (Oncological Diseases,
Genetic Diseases, Cardiovascular Diseases, Neuromuscular Diseases,
Hematological Diseases, Infectious Diseases, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F”, has evaluated
the future growth potential of UAE Gene Therapy Market and provides statistics
& information on market size, structure, and future market growth. The
report intends to provide cutting-edge market intelligence and help decision
makers take sound investment decisions. Besides, the report also identifies and
analyzes the emerging trends along with essential drivers, challenges, and
opportunities in UAE Gene Therapy Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com